PTC Therapeutics
PTCT
#3016
Rank
C$7.61 B
Marketcap
C$91.28
Share price
-1.30%
Change (1 day)
12.36%
Change (1 year)

PTC Therapeutics (PTCT) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : C$4.24 Billion

According to PTC Therapeutics 's latest financial reports the company's total liabilities are C$4.24 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

PTC Therapeutics - Total liabilities on balance sheet (from 2012 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31C$4.25 B5.68%
2024-12-31C$4.02 B11.73%
2023-12-31C$3.60 B29.25%
2022-12-31C$2.78 B12.86%
2021-12-31C$2.46 B12.13%
2020-12-31C$2.20 B63.71%
2019-12-31C$1.34 B28.44%
2018-12-31C$1.04 B253.99%
2017-12-31C$0.29 B46.94%
2016-12-31C$0.20 B4.17%
2015-12-31C$0.19 B379.08%
2014-12-31C$40.32 M146.63%
2013-12-31C$16.35 M-49.04%
2012-12-31C$32.08 M-88.84%
2011-12-31C$0.28 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
C$110.74 B 2,510.37%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
C$9.90 B 133.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
C$0.30 B-92.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
C$2.32 B-45.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
C$0.14 B-96.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
C$0.37 B-91.16%๐Ÿ‡บ๐Ÿ‡ธ USA